Uptake of lipids from ascites drives NK cell metabolic dysfunction in ovarian cancer
Science Immunology · 09.05.2025 · 10 (107)
DOI: 10.1126/sciimmunol.adr4795 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Immunology, erschienen am 09.05.2025. Verfasst von Karen Slattery und 17 weiteren Autor:innen. Beteiligte Einrichtung: School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Killer Cells, Natural, Ascites, Lipid Metabolism. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 71 Literaturangaben. Gefördert von: NIAID NIH HHS.
Abstract (Originalsprache)
High-grade serous ovarian cancer (HGSOC) remains an urgent unmet clinical need, with more than 70% of patients presenting with metastatic disease. Many patients develop large volumes of ascites, which promotes metastasis and is associated with poor therapeutic response and survival. Immunotherapy trials have shown limited success, highlighting the need to better understand HGSOC immunology. Here, we analyzed cytotoxic lymphocytes [natural killer (NK), T, and innate T cells] from patients with HGSOC and observed widespread dysfunction across primary and metastatic sites. Although nutrient rich, ascites was immunosuppressive for all lymphocyte subsets. NK cell dysfunction was driven by uptake of polar lipids, with associated dysregulation in lipid storage. Phosphatidylcholine was a key immunosuppressive metabolite, disrupting NK cell membrane order and cytotoxicity. Blocking lipid uptake through SR-B1 protected NK cell antitumor functions in ascites. These findings offer insights into immune suppression in HGSOC and have important implications for the design of future immunotherapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, Dublin, Ireland.
- Department of Cell Biology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
- Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
- Ludwig Cancer Research Institute, Princeton Branch, Princeton University, Princeton, NJ, USA.
- UCD-Gynaecological Oncology Group, School of Medicine, Mater Misericordiae University Hospital, University College Dublin, Dublin, Ireland.
- Aix Marseille Univ, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France.
ORCID-Profile: Karen Slattery, Cong-Hui Yao, John Scanlan, Barry Scott, Katie O'Brien, Kate Glennon, Rafael J Argüello, Clair M Gardiner, Marcia C Haigis, Donal J Brennan, Lydia Lynch
Förderung
- NIAID NIH HHS
Zitieren
APA
Slattery, K., Yao, C. H., Mylod, E., Scanlan, J., Scott, B., Crowley, J. P., McGowan, O., McManus, G., Brennan, M., O'Brien, K., Glennon, K., Corry, E., Treacy, A., Argüello, R. J., Gardiner, C. M., Haigis, M. C., Brennan, D. J., & Lynch, L. (2025). Uptake of lipids from ascites drives NK cell metabolic dysfunction in ovarian cancer. Science Immunology, 10(107). https://doi.org/10.1126/sciimmunol.adr4795
Vancouver
Slattery K, Yao CH, Mylod E, Scanlan J, Scott B, Crowley JP, et al. Uptake of lipids from ascites drives NK cell metabolic dysfunction in ovarian cancer. Science Immunology. 2025;10(107). doi:10.1126/sciimmunol.adr4795
BibTeX
@article{Slattery2025,
author = {Slattery, Karen and Yao, Cong-Hui and Mylod, Eimear and Scanlan, John and Scott, Barry and Crowley, Joseph Patrick and McGowan, Orla and McManus, Gavin and Brennan, Martin and O'Brien, Katie and Glennon, Kate and Corry, Edward and Treacy, Ann and Argüello, Rafael J and Gardiner, Clair M and Haigis, Marcia C and Brennan, Donal J and Lynch, Lydia},
title = {Uptake of lipids from ascites drives NK cell metabolic dysfunction in ovarian cancer},
journal = {Science Immunology},
year = {2025},
volume = {10},
number = {107},
doi = {10.1126/sciimmunol.adr4795}
}
EUVIMED